Chromadex Corp (NASDAQ: CDXC) is 202.10% higher on its value in year-to-date trading and has touched a low of $1.25 and a high of $4.06 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CDXC stock was last observed hovering at around $3.95 in the last trading session, with the day’s gains setting it 0.37%.
Currently trading at $4.32, the stock is 52.22% and 108.19% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.92 million and changing 9.37% at the moment leaves the stock 164.82% off its SMA200. CDXC registered 186.09% gain for a year compared to 6-month gain of 200.00%. The firm has a 50-day simple moving average (SMA 50) of $3.61 and a 200-day simple moving average (SMA200) of -$77.41.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 149.71% loss in the last 1 month and extending the period to 3 months gives it a 189.93%, and is 17.71% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 13.27% over the week and 14.94% over the month.
Chromadex Corp (CDXC) has around 106 employees, a market worth around $325.34M and $83.57M in sales. Fwd P/E is 75.13. Profit margin for the company is -5.91%. Distance from 52-week low is 245.60% and 6.41% from its 52-week high. The company has generated returns on investments over the last 12 months (-15.91%).
Chromadex Corp quarterly earnings per share for the current quarter are estimated at -$0.02 with sales reaching $23.97M over the same period.The EPS is expected to grow by 78.57% this year, but quarterly earnings will post 16.80% year-over-year. Quarterly sales are estimated to grow 6.30% in year-over-year returns.
68 institutions hold shares in Chromadex Corp (CDXC), with institutional investors hold 27.32% of the company’s shares. The shares outstanding are 74.98M, and float is at 44.60M with Short Float at 2.63%. Institutions hold 16.07% of the Float.
The top institutional shareholder in the company is Vanguard Group Inc with over 3.04 million shares valued at $4.78 million. The investor’s holdings represent 4.06% of the CDXC Shares outstanding. As of Jun 29, 2023, the second largest holder is Tieton Capital Management, LLC with 2.57 million shares valued at $4.04 million to account for 3.43% of the shares outstanding. The other top investors are ICONIQ Capital, LLC which holds 1.3 million shares representing 1.73% and valued at over $2.04 million, while Blackrock Inc. holds 1.22% of the shares totaling 0.91 million with a market value of $1.43 million.
Chromadex Corp (CDXC) Insider Activity
The most recent transaction is an insider purchase by Gerber Brianna, the company’s Chief Financial Officer. SEC filings show that Gerber Brianna bought 5,000 shares of the company’s common stock on Dec 01 ’23 at a price of $1.41 per share for a total of $7050.0. Following the purchase, the insider now owns 27436.0 shares.
Chromadex Corp disclosed in a document filed with the SEC on Jun 12 ’23 that Jaksch Frank L Jr (Director) bought a total of 7,000 shares of the company’s common stock. The trade occurred on Jun 12 ’23 and was made at $1.69 per share for $11830.0. Following the transaction, the insider now directly holds 0.23 million shares of the CDXC stock.
Still, SEC filings show that on May 31 ’23, Fried Robert N (Chief Executive Officer) acquired 7,000 shares at an average price of $1.42 for $9940.0. The insider now directly holds 95,001 shares of Chromadex Corp (CDXC).
